Art

J-GLOBAL ID：201702262782698710   Reference number：17A1242922

Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≧ 60 years (START-J trial)

60歳以上(START J試験)の2型糖尿病の日本人患者におけるグリメピリドと比較したシタグリプチンの有効性と安全性【Powered by NICT】

Author (20)： Terauchi Yasuo (Japan Association for Diabetes Education and Care, Tokyo, Japan) ,  Terauchi Yasuo (Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama, Japan) ,  Yamada Yuichiro (Japan Association for Diabetes Education and Care, Tokyo, Japan) ,  Yamada Yuichiro (Department of Endocrinology, Diabetes and Geriatric Medicine, Akita University School of Medicine, Akita, Japan) ,  Ishida Hitoshi (Japan Association for Diabetes Education and Care, Tokyo, Japan) ,  Ishida Hitoshi (Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Mitaka, Japan) ,  Ohsugi Mitsuru (Japan Association for Diabetes Education and Care, Tokyo, Japan) ,  Ohsugi Mitsuru (Diabetes and Metabolism Information Centre, Diabetes Research Centre, Research Institute, National Centre for Global Health and Medicine, Tokyo, Japan) ,  Kitaoka Masafumi (Japan Association for Diabetes Education and Care, Tokyo, Japan) ,  Kitaoka Masafumi (IMS Miyoshi General Hospital, Miyoshi, Japan) ,  Satoh Jo (Japan Association for Diabetes Education and Care, Tokyo, Japan) ,  Satoh Jo (Tohoku Medical and Pharmaceutical University Wakabayashi Hospital, Sendai, Japan) ,  Yabe Daisuke (Japan Association for Diabetes Education and Care, Tokyo, Japan) ,  Yabe Daisuke (Yutaka Seino Distinguished Centre for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan) ,  Yabe Daisuke (Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan) ,  Yabe Daisuke (Division of Molecular and Metabolic Medicine, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Shihara Nobuyuki (Japan Association for Diabetes Education and Care, Tokyo, Japan) ,  Seino Yutaka (Japan Association for Diabetes Education and Care, Tokyo, Japan) ,  Seino Yutaka (Yutaka Seino Distinguished Centre for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan) ,  Seino Yutaka (Centre for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan)
Material： Diabetes Obesity & Metabolism
Volume： 19  Issue： 8  Page： 1188-1192  Publication year： 2017 
JST Material Number： W2549A  ISSN： 1462-8902  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： The aim of this study was to e...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1242922&from=J-GLOBAL&jstjournalNo=W2549A") }}

Thesaurus term： blood glucose ,  *type 2 diabetes mellitus ,  randomized controlled trial ,  hypoglycemia ,  *patient ,  least squares method ,  *safety ,  base line ,  confidence interval ,  alicyclic compound ,  aromatic compound ,  lactam ,  sulfonamide ,  urea compound
Semi thesaurus term： グリコヘモグロビン ,  エンドポイント ,  高齢患者 ,  *日本人 , 【Automatic Indexing@JST】

Author keywords (5)： clinical trial ,  DPP-4 inhibitor ,  randomized trial ,  sitagliptin ,  sulphonylureas

JST classification (2)： Clinical application of drugs acting on carbohydrate metabolism  (GW13030B) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F)

Substance index (2)： Sitagliptin ,  Glimepiride

Terms in the title (8)： 試験 ,  2型糖尿病 ,  日本人 ,  患者 ,  グリメピリド ,  シタグリプチン ,  有効性 ,  安全性